SUBSCRIBE
SUBSCRIBE

Starpharma Holdings Ltd Deal With Elanco Triggers a Share Purchase Plan Extension

May 11, 2009 | 
1 min read
Melbourne, May 11, 2009 (ABN Newswire) - The Board of Starpharma Holdings Limited (ASX:SPL)(PINK:SPHRY) has decided to further extend the closing date of the share purchase plan (SPP) due to the Elanco Agreement announcement made today.
Asia Australia
MORE ON THIS TOPIC
Espionage in China concept, 3D rendering isolated on white background
Funding
RA Capital Looks to China for Next Startup To Put on SPAC Track to Nasdaq
March 25, 2026
 · 
2 min read
 · 
Tristan Manalac
Symbolic image: Tablets, US Dollar and China - Dependence on the Chinese pharmaceutical industry
Manufacturing
Novartis Pledges $480M To Expand China Presence, Following Eli Lilly and AstraZeneca
March 24, 2026
 · 
2 min read
 · 
Nick Paul Taylor
3d illustration of a national flag with a grunge metal texture
Opinion
Japan’s Drug Prices Are Creating Problems for Washington and Tokyo Alike
March 24, 2026
 · 
4 min read
 · 
John Stanford
Upward arrow on the background of the flag of China. Paper plane. Economic recovery. Copy space. Business. Background.
Manufacturing
AstraZeneca Building Shanghai Production Plant to Support Cell Therapy Strategy
March 19, 2026
 · 
2 min read
 · 
Nick Paul Taylor